Allaxys Communications --- Transponder V --- Allaxys Forum 1
Covid-Pandemie und H5N1-Pandemie - das Ende der Menschheit und vieler anderer Tierarten => Covid-Pandemie und H5N1-Pandemie => Topic started by: Julian on March 09, 2020, 07:37:37 PM
-
This is a press release by FTC and FDA about lethal claims made by mass murderers trying to sell worthless shit against Covid-19 corona virus.
Do report all such criminals to the state agencies!
https://www.ftc.gov/news-events/press-releases/2020/03/ftc-fda-send-warning-letters-seven-companies-about-unsupported
[*quote*]
Federal Trade Commission: Protecting America's Consumers
Home » News & Events » Press Releases » FTC, FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus
FTC, FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus
Commission continues efforts to protect consumers from deceptive advertising
For Release
March 9, 2020
Tags:
Health Care Over-the-Counter Drugs and Devices Bureau of Consumer Protection Consumer Protection Advertising and Marketing Health Claims
The Federal Trade Commission and U.S. Food and Drug Administration (FDA) have sent warning letters to seven companies allegedly selling unapproved products that may violate federal law by making deceptive or scientifically unsupported claims about their ability to treat coronavirus (COVID-19). The warning letters are the first issued by the agencies alleging unapproved and/or unsupported claims that products can treat or prevent coronavirus.
The agencies sent the letters to the following companies:
1) Vital Silver,
2) Quinessence Aromatherapy Ltd.,
3) N-ergetics,
4) GuruNanda, LLC,
5) Vivify Holistic Clinic,
6) Herbal Amy LLC, and
7) The Jim Bakker Show.
The recipients are companies that advertise products—including teas, essential oils, and colloidal silver—as able to treat or prevent coronavirus. According to the FDA, however, there are no approved vaccines, drugs, or investigational products currently available to treat or prevent the virus.
“There already is a high level of anxiety over the potential spread of coronavirus,” said FTC Chairman Joe Simons. “What we don’t need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims. These warning letters are just the first step. We’re prepared to take enforcement actions against companies that continue to market this type of scam.”
“The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health. We have an aggressive surveillance program that routinely monitors online sources for health fraud products, especially during a significant public health issue such as this one. The FDA’s laws are designed to protect the public health by ensuring, among other things, that drugs are safe and effective for their intended uses,” said FDA Commissioner Stephen M. Hahn, M.D.
“We understand consumers are concerned about the spread of COVID-19 and urge them to talk to their health care providers, as well as follow advice from other federal agencies about how to prevent the spread of this illness. We will continue to aggressively pursue those that place the public health at risk and hold bad actors accountable,” the FDA Commissioner concluded.
In the letters, the FTC states that one or more of the efficacy claims made by the marketers are unsubstantiated and therefore may violate the FTC Act. The letters advise the recipients to immediately cease making all claims that their products can treat or cure coronavirus.
The letters note that if the false claims do not cease, the Commission may seek a federal court injunction and an order requiring money to be refunded to consumers. Finally, they instruct the recipients to notify the FTC within 48 hours of the specific actions they have taken to address the agency’s concerns.
In addition to following up with companies that fail to make adequate corrections, the FTC and FDA will continue to monitor social media, online marketplaces, and incoming complaints to help ensure that the companies do not continue to market fraudulent products under a different name or on another website.
Information for Consumers
The FTC recently issued a new consumer blog post with information about how to identify and avoid coronavirus-related scams. Coronavirus: Scammers follow the headlines notes that scammers are setting up websites to sell bogus products, and using fake emails, texts, and social media posts as a ruse to take consumers’ money and get their personal information. It then warns consumers of the “red flags” to be aware of when shopping for products related to the virus.
The Federal Trade Commission works to promote competition, and protect and educate consumers. You can learn more about consumer topics and file a consumer complaint online or by calling 1-877-FTC-HELP (382-4357). Like the FTC on Facebook, follow us on Twitter, read our blogs, and subscribe to press releases for the latest FTC news and resources.
Contact Information
CONTACT FOR CONSUMERS:
FTC’s Consumer Response Center
877-382-4357
FTC MEDIA CONTACT:
Mitchell J. Katz
Office of Public Affairs
202-326-2161
FTC STAFF CONTACT:
Richard Cleland
Bureau of Consumer Protection
202-326-3088
Events Calendar
For Consumers
Blog: FTC, FDA warn companies making coronavirus claims
FTC.gov/coronavirus
For Businesses
Blog: FTC, FDA warn companies making coronavirus claims
[*/quote*]
-
https://www.fda.gov/news-events/press-announcements/coronavirus-update-fda-and-ftc-warn-seven-companies-selling-fraudulent-products-claim-treat-or?utm_campaign=030920_Statement_FDA%20and%20FTC%20Warn%20Companies%20for%20False%20Claims%20of%20Treating%20COVID-19&utm_medium=email&utm_source=Eloqua
[*quote*]
U.S. Food and Drug Administration
FDA News Release
Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19
For Immediate Release:
March 09, 2020
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant risks to patient health and violate federal law. The FDA and FTC are taking this action as part of their response in protecting Americans during the global COVID-19 outbreak. The warning letters are the first to be issued by the FDA for unapproved products intended to prevent or treat “Novel Coronavirus Disease 2019” (COVID-19).
“The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health. We have an aggressive surveillance program that routinely monitors online sources for health fraud products, especially during a significant public health issue such as this one,” said FDA Commissioner Stephen M. Hahn, M.D. “We understand consumers are concerned about the spread of COVID-19 and urge them to talk to their health care providers, as well as follow advice from other federal agencies about how to prevent the spread of this illness. We will continue to aggressively pursue those that place the public health at risk and hold bad actors accountable.”
“There already is a high level of anxiety over the potential spread of coronavirus,” said FTC Chairman Joe Simons. “What we don’t need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims. These warning letters are just the first step. We’re prepared to take enforcement actions against companies that continue to market this type of scam.”
The FDA is particularly concerned that products that claim to cure, treat or prevent serious diseases like COVID-19 may cause consumers to delay or stop appropriate medical treatment, leading to serious and life-threatening harm.
The FDA and FTC jointly issued warning letters to Vital Silver, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, and The Jim Bakker Show. The products cited in these warning letters are teas, essential oils, tinctures and colloidal silver. The FDA has previously warned that colloidal silver is not safe or effective for treating any disease or condition. The FDA and FTC requested companies respond in 48 hours describing the specific steps they have taken to correct the violations. Companies that sell products that fraudulently claim to prevent, treat or cure COVID-19 may be subject to legal action, including but not limited to seizure or injunction.
There are currently no vaccines or drugs approved to treat or prevent COVID-19. Although there are investigational COVID-19 vaccines and treatments under development, these investigational products are in the early stages of product development and have not yet been fully tested for safety or effectiveness.
In addition to following up with companies that fail to make adequate corrections, the FDA and FTC will continue to monitor social media, online marketplaces and incoming complaints to help ensure that the companies do not continue to sell fraudulent products under a different company name or on another website. An FDA cross-agency task force has been established and dedicated to closely monitor for fraudulent products related to COVID-19. The task force has already reached out to major retailers to ask for their help in monitoring their online marketplaces for fraudulent products claiming to combat coronavirus and other pathogens. The task force has already worked with major retailers and online marketplaces to remove more than three dozen listings of fraudulent COVID-19 products. Several have already agreed to monitor their marketplaces for COVID-19 claims.
The FDA reminds consumers to be cautious of websites and stores selling products that claim to prevent, mitigate, treat, diagnose or cure COVID-19. Fraudulent COVID-19 products may come in many varieties, including dietary supplements and other foods, as well as products purporting to be drugs, medical devices or vaccines. Products that claim to cure, mitigate, treat, diagnose or prevent disease, but are not proven safe and effective for those purposes, defraud consumers of money and can place consumers at risk for serious harm. Using these products may lead to delays in getting proper diagnosis and treatment of COVID-19 and other potentially serious diseases and conditions.
The FDA encourages health care professionals and consumers to report adverse events or quality problems experienced with the use of COVID-19 products to the FDA’s MedWatch Adverse Event Reporting program.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
###
Inquiries
Media:
Jeremy Kahn
301-796-8671
Consumer:
888-INFO-FDA
Related Information
FDA: Novel coronavirus (COVID-19)
Fraudulent Novel Coronavirus (COVID-19) Products
Fraudulent Novel Coronavirus 2019 (COVID-19) Product PhotosExternal Link Disclaimer
FTC Article on Novel Coronavirus (COVID-19) Scams
FDA Health Fraud
Reporting Unlawful Sales of Medical Products on the Internet
Content current as of:
03/09/2020
Regulated Product(s)
Dietary Supplements
Drugs
Food & Beverages
Follow FDA
Follow @US_FDA on TwitterExternal Link Disclaimer
Follow FDA on FacebookExternal Link Disclaimer
Follow @FDAmedia on TwitterExternal Link Disclaimer
Press Announcements
Footer Links
FDA Archive
About FDA
Accessibility
Visitor Information
Website Policies / Privacy
No FEAR Act
FOIA
HHS.gov
USA.gov
Follow FDA on Facebook Follow FDA on Twitter View FDA videos on YouTube Subscribe to FDA RSS feeds
FDA Homepage
Contact Number 1-888-INFO-FDA (1-888-463-6332)
[*/quote*]